当前位置:首页 - 行情中心 - 华兰生物(002007) - 财务分析

华兰生物

(002007)

  

流通市值:259.03亿  总市值:300.80亿
流通股本:15.74亿   总股本:18.27亿

华兰生物(002007)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润8.28亿元,每股收益0.43元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1324959.75万元,未分配利润724011.52万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1626736.96万元,负债301777.21万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入3,378,886,377.051,798,197,926.21867,612,696.574,379,196,621.38
营业总成本2,486,370,142.961,310,025,664.46553,612,323.283,124,967,498.36
其他经营收益
营业利润1,008,099,521.47635,103,212.79397,453,634.361,379,582,398.07
利润总额972,414,239.42611,444,107.03384,573,318.121,338,612,677.84
净利润827,700,992.33522,691,390.04323,831,368.051,155,469,792.25
每股收益
其他综合收益----
综合收益总额827,700,992.33522,691,390.04323,831,368.051,155,469,792.25
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计10,048,714,890.019,336,064,233.910,549,823,747.899,616,191,068.19
非流动资产:
非流动资产合计6,218,654,717.556,199,376,166.616,089,097,203.466,693,760,287.1
资产总计16,267,369,607.5615,535,440,400.5116,638,920,951.3516,309,951,355.29
流动负债:
流动负债合计2,926,029,063.111,465,892,254.062,368,375,746.292,360,122,055.57
非流动负债:
非流动负债合计91,743,064.7799,244,269.7797,975,500.1103,103,316.3
负债合计3,017,772,127.881,565,136,523.832,466,351,246.392,463,225,371.87
所有者权益(或股东权益):
归属于母公司股东权益合计11,371,869,789.6912,013,171,120.8412,172,136,621.0511,858,784,465.45
股东权益合计13,249,597,479.6813,970,303,876.6814,172,569,704.9613,846,725,983.42
负债和股东权益合计16,267,369,607.5615,535,440,400.5116,638,920,951.3516,309,951,355.29
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计3,106,028,325.262,049,433,728.88852,081,503.325,013,380,402.04
经营活动现金流出小计2,655,399,510.671,818,926,770.1837,902,921.613,954,035,240.16
经营活动产生的现金流量净额450,628,814.59230,506,958.7814,178,581.711,059,345,161.88
投资活动产生的现金流量:
投资活动现金流入小计9,673,231,639.897,502,570,348.644,322,547,185.3623,774,024,671.66
投资活动现金流出小计8,936,858,346.826,994,719,593.084,679,214,264.9223,683,948,699.82
投资活动产生的现金流量净额736,373,293.07507,850,755.56-356,667,079.5690,075,971.84
筹资活动产生的现金流量:
筹资活动现金流入小计724,405,900.01278,159,999.98278,704,844.44612,749,571.01
筹资活动现金流出小计1,583,602,566.451,220,104,824.1197,612,869.431,393,182,691.85
筹资活动产生的现金流量净额-859,196,666.44-941,944,824.1281,091,975.01-780,433,120.84
汇率变动对现金及现金等价物的影响175,338.16189,692.0175,438.63-52,406.71
现金及现金等价物净增加额327,980,779.38-203,397,417.77-261,321,084.21368,935,606.17
期末现金及现金等价物余额1,686,241,001.061,154,862,803.911,096,939,137.471,358,260,221.68
补充资料:
现金及现金等价物的净增加额--203,397,417.77-368,935,606.17
最新报告期:2025-09-17
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信建投汤然,刘若飞,贺菊颖0.680.770.852025-09-17
兴业证券孙媛媛,黄翰漾0.680.760.872025-09-07
野村东方国际证券孔令岩0.680.770.832025-09-02
华泰证券代雯,唐庆雷,张云逸0.750.941.122025-08-29
平安证券叶寅,倪亦道0.680.810.922025-08-28
TOP↑